This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
protein
product name :
Recombinant Human Tyrosinase (Oculocutaneous Albinism IA)
catalog :
TYR-222H
product information
Cat :
TYR-222H
Product Name :
Recombinant Human Tyrosinase (Oculocutaneous Albinism IA)
Brand :
Creative Biomart
gene symbal :
TYR
gene name :
tyrosine
Synonyms :
H-3-NITRO-L-TYROSINE; Tyr(3'-NO2); 3-nitro-l-tyrosine; NO2-L.Tyrosine; H-TYR(3-NO2)-OH; H-M-NITRO-TYR-OH; L-Tyrosine, 3-nitro-
Product Overview :
Recombinant Human Tyrosinase was produced inE. Coli.
Description :
Recombinant Human Tyrosinase was produced inE. Coli.Tyrosinase is a copper-containing metalloglycoprotein that catalyzes several steps in the melanin pigment biosynthetic pathway. Tyrosinase and melan A are the most commonly expressed melanoma markers and are found in approximately 80 to 100 per cent of cases. This antibody is of help in the identification of melanocytic tumors.
Source :
E Coli
Purity :
On SDS-PAGE commassie blue stained gel, the recombinant protein shows a band at 64kda including GST.
UniProt ID :
P14679
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments